Dengue fever as autochthonous infectious disease in Italy: epidemiological, clinical and virological characteristics.

Dengue fever autochthonous Dengue vector-borne diseases

Journal

Travel medicine and infectious disease
ISSN: 1873-0442
Titre abrégé: Travel Med Infect Dis
Pays: Netherlands
ID NLM: 101230758

Informations de publication

Date de publication:
19 Sep 2024
Historique:
received: 17 04 2024
revised: 16 09 2024
accepted: 18 09 2024
medline: 22 9 2024
pubmed: 22 9 2024
entrez: 21 9 2024
Statut: aheadofprint

Résumé

Since August to November 2023, 82 cases of autochthonous or non-travel related Dengue virus (DENV) infection have been reported in Italy, highlighting a concerning trend of local transmission. We describe the clinical and laboratory findings of 10 autochthonous DENV in the metropolitan area of Rome admitted to the Lazzaro Spallanzani National Institute for Infectious Diseases. Ten patients (3 males, 7 females; median age: 51) with classic dengue fever symptoms were admitted between August and November 2023. Laboratory tests confirmed dengue infection through DENV non-structural protein 1 and/or immunoglobulins (IgM/IgG) positive tests, moreover leukopenia, thrombocytopenia, elevated transaminases were detected. A subset of patients underwent extensive biological sampling, including real-time RT-PCR and immunofluorescence, to monitor DENV-RNA and antibody levels over 30 days. DENV-1 was detected in 8 patients and DENV-3 in 2. IgM antibodies were found in 7 patients at admission, and IgG antibodies in 4 by day 6. DENV RNA was consistently detected in blood within the first 8 days but was less common in saliva and urine. No DENV RNA was detected after day 24. These findings contribute to the understanding of the clinical course of DENV infection in a non-endemic setting as integrated epidemiological and clinical model to increase syndromic surveillance and timely diagnosis of DENV infections.

Sections du résumé

BACKGROUND BACKGROUND
Since August to November 2023, 82 cases of autochthonous or non-travel related Dengue virus (DENV) infection have been reported in Italy, highlighting a concerning trend of local transmission. We describe the clinical and laboratory findings of 10 autochthonous DENV in the metropolitan area of Rome admitted to the Lazzaro Spallanzani National Institute for Infectious Diseases.
METHOD AND RESULTS RESULTS
Ten patients (3 males, 7 females; median age: 51) with classic dengue fever symptoms were admitted between August and November 2023. Laboratory tests confirmed dengue infection through DENV non-structural protein 1 and/or immunoglobulins (IgM/IgG) positive tests, moreover leukopenia, thrombocytopenia, elevated transaminases were detected. A subset of patients underwent extensive biological sampling, including real-time RT-PCR and immunofluorescence, to monitor DENV-RNA and antibody levels over 30 days. DENV-1 was detected in 8 patients and DENV-3 in 2. IgM antibodies were found in 7 patients at admission, and IgG antibodies in 4 by day 6. DENV RNA was consistently detected in blood within the first 8 days but was less common in saliva and urine. No DENV RNA was detected after day 24.
CONCLUSION CONCLUSIONS
These findings contribute to the understanding of the clinical course of DENV infection in a non-endemic setting as integrated epidemiological and clinical model to increase syndromic surveillance and timely diagnosis of DENV infections.

Identifiants

pubmed: 39306188
pii: S1477-8939(24)00079-6
doi: 10.1016/j.tmaid.2024.102762
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102762

Informations de copyright

Copyright © 2024. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest ☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Serena Vita (S)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Via Portuense, 292, Rome 00149, Italy.

Eleonora Lalle (E)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Via Portuense, 292, Rome 00149, Italy.

Priscilla Caputi (P)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Via Portuense, 292, Rome 00149, Italy.

Francesca Faraglia (F)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Via Portuense, 292, Rome 00149, Italy.

Alessandra D'Abramo (A)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Via Portuense, 292, Rome 00149, Italy. Electronic address: alessandra.dabramo@inmi.it.

Licia Bordi (L)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Via Portuense, 292, Rome 00149, Italy.

Gabriella De Carli (G)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Via Portuense, 292, Rome 00149, Italy.

Giuseppe Sberna (G)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Via Portuense, 292, Rome 00149, Italy.

Maria Letizia Giancola (ML)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Via Portuense, 292, Rome 00149, Italy.

Gaetano Maffongelli (G)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Via Portuense, 292, Rome 00149, Italy.

Cosmina Mija (C)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Via Portuense, 292, Rome 00149, Italy.

Andrea Antinori (A)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Via Portuense, 292, Rome 00149, Italy.

Stefania Cicalini (S)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Via Portuense, 292, Rome 00149, Italy.

Fabrizio Maggi (F)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Via Portuense, 292, Rome 00149, Italy.

Enrico Girardi (E)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Via Portuense, 292, Rome 00149, Italy.

Francesco Vairo (F)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Via Portuense, 292, Rome 00149, Italy.

Emanuele Nicastri (E)

National Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Via Portuense, 292, Rome 00149, Italy.

Classifications MeSH